Not applicableTemporarily pausedNCT03322813What this trial is testingExAblate Blood Brain Barrier Disruption (BBBD) for Planned Surgery in Suspected Infiltrating GliomaWho this might be right forGlioma InSightec 15
Early research (Phase 1)WithdrawnNCT02055196What this trial is testingGenetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade GliomasWho this might be right forAdult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+3 more City of Hope Medical Center
Testing effectiveness (Phase 2)Study completedNCT01125046What this trial is testingBevacizumab in Treating Patients With Recurrent or Progressive MeningiomasWho this might be right forAcoustic SchwannomaAdult Anaplastic MeningiomaAdult Ependymoma+7 more Northwestern University 50
Testing effectiveness (Phase 2)Study completedNCT00004024What this trial is testingBiological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or OligodendrogliomaWho this might be right forBrain and Central Nervous System Tumors Barbara Ann Karmanos Cancer Institute 60
Early research (Phase 1)Study completedNCT02420613What this trial is testingVorinostat and Temsirolimus With or Without Radiation Therapy in Treating Younger Patients With Newly Diagnosed or Progressive Diffuse Intrinsic Pontine GliomaWho this might be right forDiffuse Intrinsic Pontine Glioma M.D. Anderson Cancer Center 18
Testing effectiveness (Phase 2)Study completedNCT01520870What this trial is testingSafety and Efficacy of PF-299804 (Dacomitinib), a Pan-HER Irreversible Inhibitor, in Patients With Recurrent Glioblastoma With EGFR Amplification or Presence of EGFRvIII Mutation. A Phase II CT.Who this might be right forGlioblastomaBrain Tumor, Recurrent Grupo Español de Investigación en Neurooncología 49
Testing effectiveness (Phase 2)Ended earlyNCT03904862What this trial is testingTesting the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have SurgeryWho this might be right forMedulloblastoma, ChildhoodMedulloblastoma RecurrentMedulloblastoma Pediatric Brain Tumor Consortium 21
Testing effectiveness (Phase 2)Ended earlyNCT00730262What this trial is testingEfficacy Study of TLN-4601 in Patients With Recurring Glioblastoma MultiformeWho this might be right forGlioblastoma Multiforme Thallion Pharmaceuticals 40
Early research (Phase 1)Looking for participantsNCT07087002What this trial is testingGPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young AdultsWho this might be right forMedulloblastomaCentral Nervous System Embryonal TumorRefractory Medulloblastoma+7 more Stanford University 18
Testing effectiveness (Phase 2)Study completedNCT00600054What this trial is testingPhase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine GliomaWho this might be right forRecurrent Diffuse Pontine Gliomas YM BioSciences 44
Testing effectiveness (Phase 2)Active Not RecruitingNCT03180502What this trial is testingProton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III GliomaWho this might be right forAnaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+5 more NRG Oncology 120
Early research (Phase 1)Study completedNCT00005602What this trial is testingRadiation Therapy Plus Carboplatin and Lobradimil in Treating Children With Newly Diagnosed Brain Stem GliomasWho this might be right forBrain and Central Nervous System Tumors Children's Oncology Group 13
Early research (Phase 1)Study completedNCT00003022What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Leptomeningeal CancerWho this might be right forBrain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+4 more Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT05053880What this trial is testingEvaluate Safety and Efficacy of ACT001 and Anti-PD-1 in Patients With Surgically Accessible Recurrent Glioblastoma MultiformeWho this might be right forRecurrent Glioblastoma Multiforme(GBM) Accendatech USA Inc. 48
Early research (Phase 1)Ended earlyNCT00895960What this trial is testingDasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed GlioblastomaWho this might be right forGlioblastomaCNS DiseaseBrain Diseases M.D. Anderson Cancer Center 16
Testing effectiveness (Phase 2)Study completedNCT02661282What this trial is testingAutologous CMV-Specific Cytotoxic T Cells and Temozolomide in Treating Patients With GlioblastomaWho this might be right forCytomegalovirus PositiveGlioblastomaGliosarcoma+3 more M.D. Anderson Cancer Center 65
Early research (Phase 1)Study completedNCT00472017What this trial is testingVandetanib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Diffuse Brainstem GliomaWho this might be right forBrain and Central Nervous System Tumors St. Jude Children's Research Hospital 35
Large-scale testing (Phase 3)Study completedNCT02879682What this trial is testingNTMS for Motor Mapping of Rolandic LesionsWho this might be right forGliomaBrain Metastases Technical University of Munich 330
Testing effectiveness (Phase 2)WithdrawnNCT04482933What this trial is testingHSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade GliomaWho this might be right forNeoplasmsHigh Grade GliomaGlioblastoma Multiforme+5 more Pediatric Brain Tumor Consortium
Testing effectiveness (Phase 2)Looking for participantsNCT03510208What this trial is testingPanitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing SurgeryWho this might be right forMalignant Brain NeoplasmMalignant Glioma Stanford University 46